New York State Teachers Retirement System Sells 330 Shares of Maximus, Inc. $MMS

New York State Teachers Retirement System lowered its stake in Maximus, Inc. (NYSE:MMSFree Report) by 0.5% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 72,138 shares of the health services provider’s stock after selling 330 shares during the period. New York State Teachers Retirement System owned 0.13% of Maximus worth $5,064,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the stock. Bayforest Capital Ltd bought a new stake in Maximus in the second quarter valued at $61,000. Verdence Capital Advisors LLC boosted its holdings in shares of Maximus by 3.5% during the 2nd quarter. Verdence Capital Advisors LLC now owns 7,728 shares of the health services provider’s stock valued at $542,000 after buying an additional 259 shares in the last quarter. CWM LLC boosted its holdings in shares of Maximus by 218.6% during the 2nd quarter. CWM LLC now owns 7,244 shares of the health services provider’s stock valued at $509,000 after buying an additional 4,970 shares in the last quarter. Vanguard Personalized Indexing Management LLC boosted its holdings in shares of Maximus by 32.1% during the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 8,607 shares of the health services provider’s stock valued at $604,000 after buying an additional 2,092 shares in the last quarter. Finally, Inspire Investing LLC boosted its holdings in shares of Maximus by 251.8% during the 2nd quarter. Inspire Investing LLC now owns 17,751 shares of the health services provider’s stock valued at $1,246,000 after buying an additional 12,705 shares in the last quarter. Institutional investors own 97.21% of the company’s stock.

Insiders Place Their Bets

In other Maximus news, insider Michelle F. Link sold 1,610 shares of the business’s stock in a transaction dated Wednesday, October 1st. The stock was sold at an average price of $90.86, for a total value of $146,284.60. Following the completion of the transaction, the insider owned 13,508 shares of the company’s stock, valued at approximately $1,227,336.88. The trade was a 10.65% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 1.60% of the company’s stock.

Maximus Stock Performance

Shares of Maximus stock opened at $87.15 on Tuesday. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $93.73. The firm’s 50-day moving average is $87.56 and its 200 day moving average is $76.88. The company has a debt-to-equity ratio of 0.91, a current ratio of 2.27 and a quick ratio of 2.27. The stock has a market cap of $4.91 billion, a price-to-earnings ratio of 16.05 and a beta of 0.57.

Maximus (NYSE:MMSGet Free Report) last issued its earnings results on Thursday, August 7th. The health services provider reported $2.16 earnings per share for the quarter, topping analysts’ consensus estimates of $1.39 by $0.77. Maximus had a return on equity of 24.44% and a net margin of 5.83%.The business had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.29 billion. During the same quarter in the previous year, the firm earned $1.74 EPS. Maximus’s revenue was up 2.5% on a year-over-year basis. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. Sell-side analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 1st. Shareholders of record on Friday, November 14th will be given a $0.30 dividend. The ex-dividend date of this dividend is Friday, November 14th. This represents a $1.20 dividend on an annualized basis and a yield of 1.4%. Maximus’s payout ratio is 22.10%.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on MMS. Weiss Ratings upgraded shares of Maximus from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, October 8th. Zacks Research upgraded shares of Maximus from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 26th. One investment analyst has rated the stock with a Strong Buy rating and two have issued a Buy rating to the company’s stock. Based on data from MarketBeat.com, Maximus presently has a consensus rating of “Buy” and an average target price of $90.00.

Check Out Our Latest Stock Analysis on Maximus

Maximus Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Stories

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.